The pre-seed round was backed by RAW Ventures and Cedars-Sinai Ventures to fund clinical deployment and regulatory approvals.
"We’re focused on leveraging the unique capabilities of ultrasound and developing solutions to make it smarter, faster, and more reliable, with clinicians at the centre of that transformation. This trial will assess the effectiveness of FraiyaScan in real world conditions. Importantly, the frontline staff and patient feedback will help us to understand the acceptability of the technology, where time-pressured scans, staffing gaps, and service variability, that can affect outcomes, may also impact the performance and adoption of AI-based innovations."
— Jackie Matthew, chief medical officer and clinical academic sonographer
The financing round was led by SV Health Investors and will fund initial human trials for the company lead candidate in ALS and Parkinson's.
"Developing new drugs to treat neurological diseases is very challenging, but is receiving increased interest given the high unmet medical need and growing prevalence in ageing populations."
The seed round was led by Stephen Altman, founder of New World Private Equity Partners, to support expansion of the company's marketing technology.
"This round isn’t just fuel, it’s validation. It validates the belief that marketing can be smarter, faster, and more effective when human creativity is amplified, not replaced, by AI. AMP™ gives ambitious brands the strategic edge they have been missing."
EOS Yacht Charter backed the London-based metasearch startup to fund platform growth and artificial intelligence development.
"Within the next three years, our goal is to be the company that turns the yacht charter industry upside down. We want to bring an entirely new, active, and high-spending audience into yachting — and serve as the bridge between travelers and charter partners worldwide."
